Urtica Dioica
Generic Name: urtica dioica
Brand Names:
Nettle
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: URTICA DIOICA POLLEN (.05 g/mL). Category: BLA.
Overview
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: URTICA DIOICA POLLEN (.05 g/mL). Category: BLA.
Dosage
Available as solution for intradermal, percutaneous, subcutaneous use.
Related Medications
Ombitasvir
ombitasvir
Manufactured by ABBVIE. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: DASABUVIR SODIUM (EQ 200MG BASE); OMBITASVIR (8.33MG); PARITAPREVIR (50MG); RITONAVIR (33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA208624.
Baricitinib
baricitinib
Janus Kinase Inhibitor [EPC]
11 DESCRIPTION OLUMIANT (baricitinib) is a Janus kinase (JAK) inhibitor with the chemical name {1-(ethylsulfonyl)-3-[4-(7 H -pyrrolo[2,3- d ]pyrimidin-4-yl)-1 H -pyrazol-1-yl]azetidin-3-yl}acetonitrile. Baricitinib has an empirical formula of C 16 H 17 N 7 O 2 S and a molecular weight of 371.42. Baricitinib has the following structural formula: OLUMIANT tablets contain a recessed area on each face of the tablet surface and are available for oral administration as debossed, film-coated tablets.
Aluminium Phosphate
aluminium phosphate
Dosage form: GEL. Active ingredients: ALUMINUM PHOSPHATE (20 kg/100kg). Category: DRUG FOR FURTHER PROCESSING.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.